Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 33 min ago
PreprintCC BYbioRxiv

Tfh dysfunction is associated with poor responses to HBV vaccination

2 more authors
  1. 1Department of Medicine, Division of Infectious Diseases and Immunology, NYU Grossman School of Medicine, New York CIty, NY.

Abstract

The primary goal of vaccination is to induce durable protection through generating antigen-specific humoral immunity and cellular immune memory. Yet the same vaccine may elicit protection in some and not in others. To characterize the molecular and cellular events that underlie differential vaccine responsiveness, we leveraged the known, pronounced variability in vaccine antigen-specific antibody concentration and durability observed after Hepatitis B virus (HBV) immunization. We longitudinally profiled 101 healthy adults undergoing either de novo (n=59) or booster (n=42) HBV immunizations. We then stratified participants into High ([≥]100 mIU/mL) and Low (<100 mIU/mL) Responder groups based on end-of-study titers. From this cohort, we obtained core needle biopsies (CNBx) of vaccine-draining lymph nodes from 10 participants (High Responder n=6, Low Responder n=4), 10-21 days post-final vaccination and performed single-cell RNA sequencing with paired antigen receptor sequencing. Lymph node BCR repertoire analysis revealed convergent, semi-public clonotypes across unrelated participants with elevated somatic hypermutation. Transcriptomic profiling of GC-B cells uncovered functional divergence between response groups, with High Responders showing robust activation across both dark zone (DZ) and light zone (LZ) compartments and enrichment of MYC and mTORC1 signaling. This divergence in B cell responses corresponded to notable differences in the T cell compartment. High Responders harbored a key Tfh subset marked by increased expression of CXCL13, ICOS, and GNG4, supportive of their GC localization and capacity to provide B cell help. Low Responders demonstrated a divergent program in which their GNG4+Tfh displayed aberrant inflammatory transcriptional activity despite expressing coordinated costimulatory genes necessary to provide help to LZ GC-B cells. This inflammatory signaling was associated with reduced specificity of BCL6 regulon activity despite maintained expression of canonical Tfh genes. Our data suggest that variable HBV vaccine responsiveness was associated with transcriptional aberrations in the GNG4+Tfh subset, offering a molecular framework for understanding poor vaccine responses.

Related

  1. Optimisation of metabolic dysfunction-associated steatotic liver disease (MASLD) screening algorithm for resource-poor settings using machine learning
    Chamila Mettananda, Kaveesha Sivasumithran, Lakmali Ranaweera +4
    PLOS OnePeer-reviewedCC BY 4.0Full textNeuroscienceEndocrinology & metabolismPLOS
  2. Vaccination of pregnant mares with mRNA encoding a GPI-anchored form of the virulence-associated protein A of Rhodococcus equi induces strong IgG responses that are transferred to their foals
    N. Cohen, N. M. Canaday, A. S. d. Oliveira +10
    bioRxivPreprintCC BY-NC-NDFull textImmunologybioRxiv
  3. Post-Vaccination Chemosensory Dysfunction: Changes Following SARS-CoV-2 Vaccination in a Global Study.
    Sachiko Koyama, Carla Mucignat-Caretta, Maria A Klyuchnikova +15
    Laryngoscope investigative otolaryngologyPeer-reviewedCC BY-NC-NDFull textNeuroscienceEurope PMC
  4. Intranasal adenovirus type 5 influenza vaccination enhances milk antibody responses and passive transfer to neonatal ferrets
    L. S. Stafford, P. Baker, M. Moyer +10
    bioRxivPreprintCC BYFull textMicrobiologybioRxiv
  5. Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial
    Emilien Billon, Cécile Dalban, Stephane Oudard +17
    European Urology OncologyPeer-reviewedLicence not stated6 citedGeneral biologyHAL
BibTeX
@misc{chen2026dysfunction,
  title = {{Tfh dysfunction is associated with poor responses to HBV vaccination}},
  author = {H. M. Chen and E. Severa and X. Yao and T. Williams and R. Sinha and C. Monteiro and M. Tuen and S. B. Dubensky and S. B. Koralov and C. R. Nowosad and D. A. Oldridge and L. A. Vella and A. Nellore and R. S. Herati},
  howpublished = {bioRxiv},
  year = {2026},
  month = jul,
  doi = {10.64898/2026.07.30.741822},
  url = {https://www.biorxiv.org/content/10.64898/2026.07.30.741822v2},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Tfh dysfunction is associated with poor responses to HBV vaccination
AU  - H. M. Chen
AU  - E. Severa
AU  - X. Yao
AU  - T. Williams
AU  - R. Sinha
AU  - C. Monteiro
AU  - M. Tuen
AU  - S. B. Dubensky
AU  - S. B. Koralov
AU  - C. R. Nowosad
AU  - D. A. Oldridge
AU  - L. A. Vella
AU  - A. Nellore
AU  - R. S. Herati
PY  - 2026
DA  - 2026/07/30
PB  - bioRxiv
DO  - 10.64898/2026.07.30.741822
UR  - https://www.biorxiv.org/content/10.64898/2026.07.30.741822v2
AB  - The primary goal of vaccination is to induce durable protection through generating antigen-specific humoral immunity and cellular immune memory. Yet the same vaccine may elicit protection in some and not in others. To characterize the molecular and cellular events that underlie differential vaccine responsiveness, we leveraged the known, pronounced variability in vaccine antigen-specific antibody concentration and durability observed after Hepatitis B virus (HBV) immunization. We longitudinally profiled 101 healthy adults undergoing either de novo (n=59) or booster (n=42) HBV immunizations. We then stratified participants into High ([≥]100 mIU/mL) and Low (<100 mIU/mL) Responder groups based on end-of-study titers. From this cohort, we obtained core needle biopsies (CNBx) of vaccine-draining lymph nodes from 10 participants (High Responder n=6, Low Responder n=4), 10-21 days post-final vaccination and performed single-cell RNA sequencing with paired antigen receptor sequencing. Lymph node BCR repertoire analysis revealed convergent, semi-public clonotypes across unrelated participants with elevated somatic hypermutation. Transcriptomic profiling of GC-B cells uncovered functional divergence between response groups, with High Responders showing robust activation across both dark zone (DZ) and light zone (LZ) compartments and enrichment of MYC and mTORC1 signaling. This divergence in B cell responses corresponded to notable differences in the T cell compartment. High Responders harbored a key Tfh subset marked by increased expression of CXCL13, ICOS, and GNG4, supportive of their GC localization and capacity to provide B cell help. Low Responders demonstrated a divergent program in which their GNG4+Tfh displayed aberrant inflammatory transcriptional activity despite expressing coordinated costimulatory genes necessary to provide help to LZ GC-B cells. This inflammatory signaling was associated with reduced specificity of BCL6 regulon activity despite maintained expression of canonical Tfh genes. Our data suggest that variable HBV vaccine responsiveness was associated with transcriptional aberrations in the GNG4+Tfh subset, offering a molecular framework for understanding poor vaccine responses.
ER  -